"We don’t really understand why a third of physicians believe that these are effective ovarian cancer screening tests," Dr. Baldwin commented. "But use of the USPSTF recommendations, and practice in settings that promote interactions between physicians, like group practices, may help dispel misconceptions about the effectiveness of the ovarian cancer screening tests."
"Further research is definitely needed to try to understand what’s going on with these misconceptions and the contribution of potential risk assessment errors to this screening," she concluded.
Dr. Baldwin reported that she had no relevant financial conflicts of interest.